Sionna Therapeutics (SION) Non Operating Income (2024 - 2026)

Sionna Therapeutics (SION) has 3 years of Non Operating Income data on file, last reported at $2.8 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income fell 11.24% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2026 stood at $13.4 million (up 24.31% YoY), and the FY2025 full-year result was $13.7 million, up 54.65% from the prior year.
• Non Operating Income slipped to $2.8 million in Q1 2026, from $3.2 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $3.8 million in Q2 2025 to a low of $1.3 million in Q1 2024.
• A 3-year average of $2.8 million and a median of $2.8 million in 2026 frame the typical range for Non Operating Income.
• Across the five-year window, Non Operating Income soared 144.38% in 2025 and fell 11.24% in 2026, its largest moves.
• Tracing SION's Non Operating Income over 3 years: stood at $2.3 million in 2024, then surged by 38.82% to $3.2 million in 2025, then fell by 11.1% to $2.8 million in 2026.
• Business Quant data shows SION's Non Operating Income at $2.8 million in Q1 2026, $3.2 million in Q4 2025, and $3.5 million in Q3 2025.